期刊文献+

CHFR基因在鼻咽癌中异常甲基化的研究 被引量:1

Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma
原文传递
导出
摘要 目的:检测鼻咽癌中CHFR基因的转录表达及其启动子区甲基化状态,探讨其在鼻咽癌中的转录失活机制及其意义;评价鼻咽拭子检测CHFR基因甲基化状态在鼻咽癌诊断和治疗中的意义。方法:RT-PCR检测鼻咽癌细胞株中CHFR基因的转录表达水平。甲基化特异性PCR检测鼻咽癌细胞株、鼻咽癌活检组织、正常鼻咽组织及配套的鼻咽拭子样本中CHFR基因的甲基化状态。亚硫酸氢盐测序分析鼻咽癌细胞株和鼻咽癌组织、正常鼻咽组织中CHFR基因启动子区的具体甲基化状态。5-氮杂-2'-脱氧胞苷(5-aza-dC)处理鼻咽癌细胞株后观察CHFR基因转录表达水平的改变情况。结果:CHFR基因在鼻咽癌细胞株中转录表达下调或沉默;CHFR基因在鼻咽癌细胞株和鼻咽癌组织中均呈高频率、肿瘤特异性的甲基化。鼻咽癌患者鼻咽癌组织和配套鼻咽拭子样本中CHFR基因的甲基化频率分别为65.5%和63.8%,两者符合率达86.2%。鼻咽癌组织和细胞株中CHFR基因启动子区大部分的CpG位点为甲基化,而正常组织全为非甲基化;5-aza-dC可显著恢复鼻咽癌细胞株中CHFR基因的转录表达。结论:鼻咽癌中CHFR基因由于启动子区CpG岛的DNA甲基化而转录表达下调。鼻咽癌中CHFR基因的甲基化与患者T分期相关。检测鼻咽拭子中甲基化的CHFR基因可望作为鼻咽癌无创诊断的手段之一。 Objective:To discover the relationship of transcriptional levels and promoter methylation status of CHFR gene in human nasopharyngeal carcinoma,to discuss the significance and epigenetic mechanism of CHFR inactivation in NPC,and to evaluate the feasibility of detecting methylated CHFR in nasopharyngeal swab as a means for diagnosis of NPC.Method:Transcriptional levels of CHFR was evaluated by RT-PCR.Methylation specific PCR was used to detect the methylation status of CHFR in NPC cells,normal nasopharyngeal epithelia,primary tumors and their paired nasopharyngeal swabs.Detailed methylation status was confirmed by bisulfite sequencing.NPC cells were treated by the methyaltransfrase inhibitor 5-aza-dC and the reactivation of CHFR was evaluated by RT-PCR.Result:CHFR transcription was inactivated in NPC.The methylation frequency in NPC primary tumors and their paired swabs were 65.5% and 63.8%,respectively,with a 86.2% concordance.Bisulfite sequencing revealed a dense methylation in NPC cells and primary tumors,but all the normal nasopharyngeal epithelia were unmethylated.CHFR expression were restored after 5-aza-dC treatment.Conclusion:CHFR is epigenetically inactivated by promoter methylation in NPC.Detecting methylated CHFR can be served as a useful non-invasive means for diagnosis of NPC.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2011年第16期746-750,共5页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 国家自然科学基金(No:30960416) 广西科学基金(No:桂科青0728052)
关键词 鼻咽肿瘤 CHFR基因 鼻咽拭子 DNA甲基化 nasopharyngeal neoplasms CHFR nasopharyngeal Swab DNA methylation
  • 相关文献

参考文献2

二级参考文献18

  • 1韩瑞珠,李晓丹,王鑫,徐秀玉,周梁.凋亡相关基因在喉鳞癌中的表达概况[J].肿瘤,2005,25(4):331-334. 被引量:6
  • 2QIU G,FANG J,HE Y.5'CpG island methylation analysis identifies the MAGM-Al and MAGM-A3 genes as potential markers of HCC[J].Clin Biochem,2006,39:259-266.
  • 3FEINBERG A P,OHLSSON R,HENIKOFF S.The epigenetic progenitor origin of human cancer[J].Nat Rev Genet,2006,7:21-33.
  • 4CORN P G,SUMMERS M K,FOGT F,et al.Frequent hypermethylation of the 5'CpG island of the mitotie stress checkpoint gene Chfr in colorectal and nonsmall cell lung cancer[J].Carcinogenesis,2003,24:47-51.
  • 5TOYOTA M,SASAKI Y,SATOH A F.et al.Epigenetic inactivation of CHFR in human tumors[J].Proc Natl Acad Sci U S A,2003,100:7818-7823.
  • 6CHEUNG H W,CHING Y P,NICHOLLS J M,et al.Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation[J].Mol Carcinog,2005,43:237-245.
  • 7NEPHEW K P,HUANG T H.Epigenetic gene silencing in cancer initiation and progression[J].Cancer Lett,2003,190:125-133.
  • 8SCOLNICK D M,HALAZONETIS T D.Chfr defines a mitotic stress checkpoint that delays entry into metaphase[J].Nature.2000,406:430-435.
  • 9CHATURVEDI P,SUDAKIN V,BOBIAK M L,et al.Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity[J].Cancer Res,2002,62:1797-1801.
  • 10KANG D,CHEN J,WONG J,et al.The checkpoint protein Chfr is a ligase that ubiquitinates Plkl and inhibits Cdc2 at the G2 to M transition[J].J Cell Biol,2002,156:249-259.

共引文献10

同被引文献21

  • 1倪海峰,莫颖禧,周晓莹,张哲,黄光武.P14^(ARF)和P16^(INK4a)基因在鼻咽癌组织中异常甲基化及其临床意义[J].广西医学院学报,2008,18(3):341-343. 被引量:5
  • 2周亮,任彩萍,单文姣,姚开泰.DNAJC10基因在鼻咽癌中的表达及表达下调机制的研究[J].生命科学研究,2006,10(4):362-366. 被引量:1
  • 3文进,李幼平.Meta分析中效应尺度指标的选择[J].中国循证医学杂志,2007,7(8):606-613. 被引量:128
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics [J] . CA Cancer J Clin, 2011 , 61 (2) : 69-90.
  • 5Welberg L. Epigenetics . keeping it in the family [J]. Nat Rev Neurosci, 2013, 14(7) : 458-459.
  • 6Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments [J]. Expert Rev Mol Med, 2007, 9 ( 12) :21-24.
  • 7Xiao X, Zhao W, Tian F, et al. Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma [J]. Tumour Bioi, 2014,35(4) :3755-3763.
  • 8Yang Z, Lan H, Chen X, et al. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma [J]. N eoplasma, 2014, 61 (2) : 170-176.
  • 9Du C, Huang T, Sun 0, et al. CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma [J]. Cancer Lett, 20 II, 309 (l) : 54-61.
  • 10Liu XQ, Chen HK, Zhang XS, et al. Alterations of Blu, a candidate tumor suppressor gene on chromosome 3 p21. 3, in human nasopharyngeal carcinomaj J]. Int J Cancer, 2003, 106 ( 1) :60-65.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部